These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

330 related items for PubMed ID: 27236602

  • 1. A randomized, single-blind, prospective trial comparing three different gonadotropin doses with or without addition of letrozole during ovulation stimulation in patients with poor ovarian response.
    Bastu E, Buyru F, Ozsurmeli M, Demiral I, Dogan M, Yeh J.
    Eur J Obstet Gynecol Reprod Biol; 2016 Aug; 203():30-4. PubMed ID: 27236602
    [Abstract] [Full Text] [Related]

  • 2. Management of poor responders: can outcomes be improved with a novel gonadotropin-releasing hormone antagonist/letrozole protocol?
    Schoolcraft WB, Surrey ES, Minjarez DA, Stevens JM, Gardner DK.
    Fertil Steril; 2008 Jan; 89(1):151-6. PubMed ID: 17482177
    [Abstract] [Full Text] [Related]

  • 3. Effectiveness of cetrorelix for the prevention of premature luteinizing hormone surge during controlled ovarian stimulation using letrozole and gonadotropins: a randomized trial.
    Lee TH, Lin YH, Seow KM, Hwang JL, Tzeng CR, Yang YS.
    Fertil Steril; 2008 Jul; 90(1):113-20. PubMed ID: 18054932
    [Abstract] [Full Text] [Related]

  • 4. Ovulation induction and controlled ovarian stimulation using letrozole gonadotropin combination: A single center retrospective cohort study.
    Arya S, Kupesic-Plavsic S, Mulla ZD, Dwivedi AK, Crisp Z, Jose J, Noble LS.
    Eur J Obstet Gynecol Reprod Biol; 2017 Nov; 218():123-128. PubMed ID: 28985546
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Effect of domestic highly purified urinary follicle stimulating hormone on outcomes of in vitro fertilization-embryo transfer in controlled ovarian stimulation].
    Ye H, Huang GN, Cao YX, Zhong Y, Huang YH, Zhu GJ, Zhou LM, Chen ZJ, Shi JZ, Zeng Y, Weng N, Huang XF, Yang J, Zhu YM, Li YP, Yi D, Zhuang GL.
    Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):838-42. PubMed ID: 24444561
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Use of letrozole and clomiphene citrate combined with gonadotropins in clomiphene-resistant infertile women with polycystic ovary syndrome: a prospective study.
    Xi W, Liu S, Mao H, Yang Y, Xue X, Lu X.
    Drug Des Devel Ther; 2015 Nov; 9():6001-8. PubMed ID: 26648691
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. A randomized single-blind controlled trial of letrozole as a low-cost IVF protocol in women with poor ovarian response: a preliminary report.
    Goswami SK, Das T, Chattopadhyay R, Sawhney V, Kumar J, Chaudhury K, Chakravarty BN, Kabir SN.
    Hum Reprod; 2004 Sep; 19(9):2031-5. PubMed ID: 15217999
    [Abstract] [Full Text] [Related]

  • 12. Letrozole usage adjuvant to gonadotropins for ovulation induction for patients with clomiphene citrate failure.
    Ozdemir U, Ozaksit G, Cakir Gungor AN, Aydogan M.
    Arch Gynecol Obstet; 2013 Aug; 288(2):445-8. PubMed ID: 23471549
    [Abstract] [Full Text] [Related]

  • 13. Is the modified natural in vitro fertilization cycle justified in patients with "genuine" poor response to controlled ovarian hyperstimulation?
    Kedem A, Tsur A, Haas J, Yerushalmi GM, Hourvitz A, Machtinger R, Orvieto R.
    Fertil Steril; 2014 Jun; 101(6):1624-8. PubMed ID: 24680364
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Highly purified hMG versus recombinant FSH plus recombinant LH in intrauterine insemination cycles in women ≥35 years: a RCT.
    Moro F, Scarinci E, Palla C, Romani F, Familiari A, Tropea A, Leoncini E, Lanzone A, Apa R.
    Hum Reprod; 2015 Jan; 30(1):179-85. PubMed ID: 25398971
    [Abstract] [Full Text] [Related]

  • 17. A comparison of outcomes from in vitro fertilization cycles stimulated with either recombinant luteinizing hormone (LH) or human chorionic gonadotropin acting as an LH analogue delivered as human menopausal gonadotropins, in subjects with good or poor ovarian reserve: a retrospective analysis.
    Dahan MH, Agdi M, Shehata F, Son W, Tan SL.
    Eur J Obstet Gynecol Reprod Biol; 2014 Jan; 172():70-3. PubMed ID: 24314801
    [Abstract] [Full Text] [Related]

  • 18. Effects of Letrozole-HMG and Clomiphene-HMG on Incidence of Luteinized Unruptured Follicle Syndrome in Infertile Women Undergoing Induction Ovulation and Intrauterine Insemination: A Randomised Trial.
    Azmoodeh A, Pejman Manesh M, Akbari Asbagh F, Ghaseminejad A, Hamzehgardeshi Z.
    Glob J Health Sci; 2015 Sep 01; 8(4):244-52. PubMed ID: 26573024
    [Abstract] [Full Text] [Related]

  • 19. Effect of letrozole at 2.5 mg or 5.0 mg/day on ovarian stimulation with gonadotropins in women undergoing intrauterine insemination.
    Noriega-Portella L, Noriega-Hoces L, Delgado A, Rubio J, Gonzales-Castañeda C, Gonzales GF.
    Fertil Steril; 2008 Nov 01; 90(5):1818-25. PubMed ID: 18083169
    [Abstract] [Full Text] [Related]

  • 20. Extended high dose letrozole regimen versus short low dose letrozole regimen as an adjuvant to gonadotropin releasing hormone antagonist protocol in poor responders undergoing IVF-ET.
    Fouda UM, Sayed AM.
    Gynecol Endocrinol; 2011 Dec 01; 27(12):1018-22. PubMed ID: 21714697
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.